Total records
16,790
Drug Enforcements
Analyze FDA drug enforcement notices, including classifications, firms, and recall scope.
Most recent report
September 24, 2025
Last updated
September 30, 2025
Drug Enforcement Records
Sorted by most recent report date.
Back to datasets
Page 655 of 672
| Recall # | Product | Firm | Status | Classification | Report date |
|---|---|---|---|---|---|
| D-106-2013 | Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01 | Hospira Inc. | Terminated | Class II | Jan 9, 2013 |
| D-123-2013 | Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-108-2013 | Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class I | Jan 9, 2013 |
| D-110-2013 | Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class I | Jan 9, 2013 |
| D-119-2013 | Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-120-2013 | Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-114-2013 | Bupivacaine 0.25% PF, Bupivacaine 0.5% PF, and Bupivacaine 0.75% PF, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-112-2013 | Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P Injection, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-118-2013 | Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-122-2013 | Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA | New England Compounding Center | Terminated | Class II | Jan 9, 2013 |
| D-100-2013 | Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. | Lloyd Inc. of Iowa | Terminated | Class II | Jan 2, 2013 |
| D-104-2013 | Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR | Alara Pharmaceutical Co | Terminated | Class II | Jan 2, 2013 |
| D-101-2013 | Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. | Lloyd Inc. of Iowa | Terminated | Class II | Jan 2, 2013 |
| D-102-2013 | Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA | Lloyd Inc. of Iowa | Terminated | Class II | Jan 2, 2013 |
| D-103-2013 | Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. | Lloyd Inc. of Iowa | Terminated | Class II | Jan 2, 2013 |
| D-105-2013 | Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom | F. Hoffmann-LaRoche Ltd. | Terminated | Class II | Jan 2, 2013 |
| D-096-2013 | Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01 | Hospira, Inc. | Terminated | Class II | Dec 26, 2012 |
| D-095-2013 | Choletec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box, Nonradioactive, Diagnostic Use, For Intravenous Use, Multidose, Rx Only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ 08543, by Hollister-Stier Laboratories LLC, Spokane Washington 99207, NDC 0270-0083-20. | Bracco Diagnostic Inc | Terminated | Class III | Dec 26, 2012 |
| D-093-2013 | Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA 91320; Dist. By: Physicians Total Care, Tulsa, OK 74146; NDC 54868-5673-1. | Physicians Total Care, Inc. | Terminated | Class II | Dec 26, 2012 |
| D-094-2013 | Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880. | Watson Laboratories Inc | Terminated | Class III | Dec 26, 2012 |
| D-097-2013 | CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080. | Genentech, Inc. | Terminated | Class III | Dec 26, 2012 |
| D-098-2013 | Clean & Clear advantage, 3-in-1 foaming wash 8 FL. OZ. (240 mL) bottle, OTC, Distributed in the US by: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies Inc. Skillman, NJ 08558-9418 NDC 58232-0326-8 | Johnson & Johnson | Terminated | Class III | Dec 26, 2012 |
| D-099-2013 | Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02. | Hospira, Inc. | Terminated | Class II | Dec 26, 2012 |
| D-090-2013 | Enjuvia (synthetic conjugated estrogens, B) tablets, 0.3mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6164-1. | Physicians Total Care, Inc. | Terminated | Class III | Dec 19, 2012 |
| D-092-2013 | Enjuvia (synthetic conjugated estrogens, B) tablets, 0.9mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6165-1. | Physicians Total Care, Inc. | Terminated | Class III | Dec 19, 2012 |